Download the mobile app to read all the abstracts and posters and see the complete schedule of events. You can also set and save your schedule and message other attendees. You may also download the final program.
May 2-5, 2019
Help Advance OA Research
Why You Should Join OARSI
The editors of the journal Osteoarthritis and Cartilage announce a request for original research papers for a special themed issue addressing “Innate Immunity in OA”.
The Pre-Competitive Consortium for OA (PCCOA) was created by OARSI more than a decade ago in response to a Federal Register Notice seeking a critical appraisal on a number of questions that would help to inform the updating of the 1999 guidance for Clinical Development Programs for the Treatment and Prevention OA. Subsequently in 2016, OARSI submitted a White Paper to the FDA providing a comprehensive review and rationale for OA to be defined as a potentially serious disease and to demonstrate that evidence from numerous data analyses provided justification for consideration of the use of surrogate markers in studies of some patients with OA for the early approval...
By Multiple Authors
For the first time, OARSI has developed treatment guidelines tailored to different types of patients with osteoarthritis (OA) of the knee. These...